BACKGROUND AND OBJECTIVES
Plasma phospho-tau217 (p-tau 217) is a validated biomarker of Alzheimer disease (AD), and its longitudinal dynamics may reflect AD progression. Plasma neurofilament light chain (NfL) reflects axonal injury and neurodegeneration. Their trajectories may be modulated by concomitant proteinopathie...
D. Esteller-Gauxax, Agnès Pérez-Millán, J. Sarto et al.· Neurology· 0 citations
The locus coeruleus (LC), the earliest site of tau accumulation in Alzheimer’s disease, directly influences pupillary and vergence oculomotor systems. Whether task-evoked oculomotor dynamics can non-invasively differentiate AT(N) profiles, A+T+ (biological Alzheimer’s disease) and A−T+ (suspected non-Alzheimer’s tauopa...
Abstract Sleep disturbances are frequently observed in patients with neurodegenerative diseases, but in vivo evidence linking subcortical sleep–wake structures to sleep phenotypes is limited. We aim to examine associations between MRI-derived measures of subcortical sleep–wake regulating regions and polysomnographic sl...